Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,488 | 27,535 | 28,892 | 15,250 | 14,010 |
| Marketable Securities | 49,367 | 59,877 | 10,291 | 40,132 | 59,796 |
| Receivables | 42,911 | 48,906 | 46,893 | 46,384 | 40,433 |
| Inventories | 13,678 | 12,174 | 12,168 | 10,254 | 9,261 |
| TOTAL | $143,493 | $152,682 | $104,071 | $118,962 | $130,418 |
| Non-Current Assets | |||||
| PPE Net | 10,883 | 10,787 | 10,772 | 9,846 | 8,547 |
| Investments And Advances | 0 | 0 | 58,944 | 58,841 | 58,354 |
| Intangibles | 25,134 | 25,791 | 26,574 | 21,779 | 39,375 |
| Other Non-Current Assets | 29,730 | 29,093 | 29,598 | 25,205 | 24,971 |
| TOTAL | $65,747 | $65,671 | $125,888 | $115,671 | $131,247 |
| Total Assets | $209,240 | $218,353 | $229,959 | $234,633 | $261,665 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,429 | 13,333 | 13,123 | 11,946 | 9,372 |
| Accrued Expenses | 13,996 | 12,723 | 14,126 | 12,245 | 14,595 |
| TOTAL | $34,788 | $32,390 | $33,506 | $30,085 | $29,720 |
| Non-Current Liabilities | |||||
| Long Term Debt | 86,826 | 85,254 | 83,688 | 82,144 | 80,621 |
| Other Non-Current Liabilities | 30,569 | 28,702 | 27,965 | 23,916 | 28,041 |
| TOTAL | $117,427 | $114,114 | $111,731 | $106,142 | $108,770 |
| Total Liabilities | $152,215 | $146,504 | $145,237 | $136,227 | $138,490 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,313 | 73,749 | 72,955 | 75,351 | 74,552 |
| Common Shares | 8 | 8 | 7 | 7 | 7 |
| Retained earnings | -146,150 | -127,396 | -109,977 | -93,080 | -63,082 |
| Other shareholders' equity | -19 | -19 | 106 | 0 | 0 |
| TOTAL | $57,025 | $71,849 | $84,722 | $98,406 | $123,175 |
| Total Liabilities And Equity | $209,240 | $218,353 | $229,959 | $234,633 | $261,665 |